MEDIROM Healthcare Technologies Inc.
MRM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $8,299 | $6,828 | $6,954 | $5,410 |
| % Growth | 21.5% | -1.8% | 28.5% | – |
| Cost of Goods Sold | $6,053 | $5,259 | $5,052 | $3,994 |
| Gross Profit | $2,246 | $1,569 | $1,902 | $1,415 |
| % Margin | 27.1% | 23% | 27.4% | 26.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2,086 | $1,798 | $1,670 | $1,680 |
| SG&A Expenses | $2,242 | $1,960 | $1,805 | $1,811 |
| Sales & Mktg Exp. | $155 | $162 | $135 | $131 |
| Other Operating Expenses | $23 | $0 | $0 | $75 |
| Operating Expenses | $2,264 | $1,960 | $1,805 | $1,886 |
| Operating Income | -$18 | -$392 | $97 | -$471 |
| % Margin | -0.2% | -5.7% | 1.4% | -8.7% |
| Other Income/Exp. Net | $66 | $412 | $83 | $56 |
| Pre-Tax Income | $48 | $21 | $180 | -$414 |
| Tax Expense | -$90 | -$94 | $31 | $576 |
| Net Income | $149 | $115 | $149 | -$991 |
| % Margin | 1.8% | 1.7% | 2.1% | -18.3% |
| EPS | 29.13 | 23.64 | 30.54 | -203.13 |
| % Growth | 23.2% | -22.6% | 115% | – |
| EPS Diluted | 28.52 | 22.27 | 27.23 | -203.13 |
| Weighted Avg Shares Out | 5 | 5 | 5 | 5 |
| Weighted Avg Shares Out Dil | 6 | 5 | 5 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $6 | $1 |
| Interest Expense | $50 | $37 | $10 | $12 |
| Depreciation & Amortization | $290 | $253 | $184 | $126 |
| EBITDA | $387 | $310 | $374 | -$276 |
| % Margin | 4.7% | 4.5% | 5.4% | -5.1% |